Tetracycline-regulated bone morphogenetic protein 2 gene expression in lentivirally transduced primary rabbit chondrocytes for treatment of cartilage defects.
Wübbenhorst
Daniela
D
Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Dumler
Katja
K
Wagner
Bettina
B
Wexel
Gabriele
G
Imhoff
Andreas
A
Gansbacher
Bernd
B
Vogt
Stephan
S
Anton
Martina
M
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D055396:Bone Morphogenetic Protein 2 / Q000235:genetics* / Q000378:metabolism; D002358:Cartilage, Articular / Q000187:drug effects* / Q000293:injuries / Q000378:metabolism; D002478:Cells, Cultured; D019902:Chondrocytes / Q000187:drug effects* / Q000378:metabolism; D020219:Chondrogenesis / Q000187:drug effects*; D005260:Female; D015870:Gene Expression / Q000187:drug effects*; D015316:Genetic Therapy; D005822:Genetic Vectors; D016086:Lentivirus; D011817:Rabbits; D013752:Tetracycline / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D055396:Bone Morphogenetic Protein 2; D013752:Tetracycline